Variables | All Subjects (nā=ā44) | No Conversion (nā=ā31) | Conversion (nā=ā13) | PāValue | |||
---|---|---|---|---|---|---|---|
Mean | Std. Dev | Mean | Std. Dev | Mean | Std. Dev | ||
Independent Sample T-Test | |||||||
Age (years) | 49.57 (26ā76) | 14.09 | 48.16 (26ā76) | 15.42 | 52.92 (33ā67) | 9.96 | 0.312 |
BMI | 25.31 (15.03ā40.40) | 5.34 | 24.16 (15.03ā40.40) | 5.16 | 28.05 (21.26ā38.44) | 4.90 | 0.026** |
Hemoglobin Level (g/dL) | 12.93 (9.9ā16.7) | 1.35 | 12.90 (9.9ā16.7) | 1.48 | 12.99 (11.5ā14.6) | 1.04 | 0.852 |
Leucocytes Count (Ćā109/L) | 8.66 (3.70ā15.60) | 2.84 | 7.78 (3.70ā13.20) | 2.16 | 10.75 (6.40ā15.60) | 3.23 | 0.001** |
Indirect Bilirubin (mg/dL) | 0.46 (0.08ā1.10) | 0.21 | 0.41 (0.1ā0.7) | 0.17 | 0.59 (0.08ā1.10) | 0.25 | 0.008** |
Mann Whitney U Test | |||||||
NeutrophilāLymphocyte Ratio* | 3.34 (0.95ā21.44) | 3.79 | 2.29 (0.95ā8.06) | 1.25 | 5.85 (1.71ā21.44) | 6.17 | 0.052 |
AST / SGOT* (U/L) | 20.57 (6ā46) | 7.99 | 20.84 (6ā46) | 8.50 | 19.92 (12ā35) | 6.89 | 0.651 |
ALT / SGPT* (U/L) | 27.49 (11ā96) | 20.09 | 28.31 (11.0ā96.0) | 20.77 | 25.54 (12ā76) | 19.03 | 0.303 |
Total Bilirubin* (mg/dL) | 0.81 (0.3ā2.2) | 0.34 | 0.72 (0.3ā1.2) | 0.26 | 1.02 (0.6ā2.2) | 0.42 | 0.015** |
Direct Bilirubin* (mg/dL) | 0.36 (0.1ā1.1) | 0.19 | 0.32 (0.1ā0.7) | 0.18 | 0.43 (0.20ā1.10) | 0.23 | 0.049** |
Adhesion | Ā | Ā | Ā | Ā | Ā | Ā | 0.000** |
Gall Bladder Stone Count | Ā | Ā | Ā | Ā | Ā | Ā | 0.853 |
Post-Surgery Hospitalization* (days) | 2.43 (2ā5) | 0.73 | 2.10 (2ā3) | 0.30 | 3.23 (2ā5) | 0.83 | 0.000** |
Surgery Duration (minutes)* | 42.61 (20ā75) | Ā | 38.87 (20ā75) | 10.22 | 51.54 (30ā70) | 10.87 | 0.001** |
Chi Square Test | |||||||
Ā Gender | Ā | Ā | Ā | Ā | Ā | Ā | 0.166 |
Ā Cholecystitis Clinical Manifestation | Ā | Ā | Ā | Ā | Ā | Ā | 0.201 |
Ā USG Cholecystitis Findings | Ā | Ā | Ā | Ā | Ā | Ā | 0.000** |
Ā Microscopic Findings | Ā | Ā | Ā | Ā | Ā | Ā | 0.000** |